SXTC vs. APVO, ADTX, CMRA, HSTO, BLPH, ATHX, AMPE, EVFM, SPRC, and EVLO
Should you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include Aptevo Therapeutics (APVO), Aditxt (ADTX), Comera Life Sciences (CMRA), Histogen (HSTO), Bellerophon Therapeutics (BLPH), Athersys (ATHX), Ampio Pharmaceuticals (AMPE), Evofem Biosciences (EVFM), SciSparc (SPRC), and Evelo Biosciences (EVLO). These companies are all part of the "pharmaceutical preparations" industry.
China SXT Pharmaceuticals (NASDAQ:SXTC) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership.
5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.1% of Aptevo Therapeutics shares are owned by institutional investors. 4.0% of China SXT Pharmaceuticals shares are owned by company insiders. Comparatively, 0.3% of Aptevo Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
China SXT Pharmaceuticals has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Aptevo Therapeutics has a beta of 5.13, meaning that its share price is 413% more volatile than the S&P 500.
In the previous week, Aptevo Therapeutics had 7 more articles in the media than China SXT Pharmaceuticals. MarketBeat recorded 10 mentions for Aptevo Therapeutics and 3 mentions for China SXT Pharmaceuticals. China SXT Pharmaceuticals' average media sentiment score of 1.59 beat Aptevo Therapeutics' score of 0.41 indicating that China SXT Pharmaceuticals is being referred to more favorably in the media.
Aptevo Therapeutics received 116 more outperform votes than China SXT Pharmaceuticals when rated by MarketBeat users. However, 61.65% of users gave China SXT Pharmaceuticals an outperform vote while only 52.66% of users gave Aptevo Therapeutics an outperform vote.
China SXT Pharmaceuticals' return on equity of 0.00% beat Aptevo Therapeutics' return on equity.
China SXT Pharmaceuticals has higher earnings, but lower revenue than Aptevo Therapeutics.
Summary
China SXT Pharmaceuticals beats Aptevo Therapeutics on 7 of the 13 factors compared between the two stocks.
Get China SXT Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SXTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
China SXT Pharmaceuticals Competitors List
Related Companies and Tools
